Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | CASP1 | P29466 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | CD44 | P16070 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2037027 | 0.88 | ALDH1A1 (0.34) | TDP1CYP3A4ALDH1A1TSHRTP53 | |
| SCHEMBL3875795 | 0.84 | CYP3A4 (0.33) | TDP1CYP3A4ALDH1A1TSHRCASP1 | |
| SCHEMBL8973695 | 0.80 | CD44 (0.48) | TDP1CYP3A4ALDH1A1TSHRTRPA1 | |
| SCHEMBL7571572 | 0.79 | HIF1A (0.32) | ALDH1A1 | |
| SCHEMBL1532606 | 0.76 | CYP3A4 (0.37) | TDP1CYP3A4ALDH1A1TSHRCASP1 | |
| SCHEMBL6397577 | 0.74 | TRPA1 (0.40) | TDP1CYP3A4ALDH1A1TSHRCASP1 | |
| SCHEMBL6122863 | 0.74 | CYP3A4 (0.31) | CYP3A4TSHR | |
| SCHEMBL688608 | 0.74 | TSHR (0.46) | TDP1CYP3A4ALDH1A1TSHRMAPT | |
| SCHEMBL4852014 | 0.73 | CYP3A4 (0.43) | TDP1CYP3A4ALDH1A1TSHRCASP1 | |
| SCHEMBL5830708 | 0.72 | LMNA (0.38) | TDP1CYP3A4ALDH1A1TSHRCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3700465-B1 | ENDOLUMINAL DEVICE AND POLYMER | ENDOLOGIX LLC (US) | 2025-07-16 | — | — | EP | claimed |
| US-12240973-B2 | Endoluminal device and polymer | ENDOLOGIX LLC (US) | 2025-03-04 | — | — | US | claimed |
| US-20200324018-A1 | ENDOLUMINAL DEVICE AND POLYMER | SILICON VALLEY BANK | 2020-10-15 | — | — | US | claimed |
| EP-3700465-A1 | ENDOLUMINAL DEVICE AND POLYMER | Endologix, Inc. (US) | 2020-09-02 | — | — | EP | claimed |
| WO-2018071920-A1 | CURABLE URETHANE DIMETHACRYLATES AND DENTAL RESTORATIVE COMPOSITIONS THEREOF | DM HEALTHCARE PRODUCTS, INC (US) | 2018-04-19 | — | — | WO | claimed |
| US-9523029-B2 | Two-component mortar composition and its use | HILTI AKTIENGESELLSCHAFT (LI) | 2016-12-20 | — | — | US | claimed |
| EP-2640675-B1 | TWO-COMPONENT MORTAR COMPOSITION AND ITS USE | HILTI AG (LI) | 2015-09-09 | — | — | EP | claimed |
| EP-2640675-A1 | TWO-COMPONENT MORTAR COMPOSITION AND ITS USE | HILTI Aktiengesellschaft (LI) | 2013-09-25 | — | — | EP | claimed |
| US-20130237634-A1 | Two-Component Mortar Composition and its Use | HILTI AKTIENGESELLSCHAFT (LI) | 2013-09-12 | — | — | US | claimed |
| US-20130213549-A1 | ADHESIVE AND METHOD FOR BINDING ARTIFICIAL PLASTIC TEETH | DENTSPLY INTERNATIONAL INC. (US) | 2013-08-22 | — | — | US | claimed |
| WO-2009110848-A1 | LOW SHRINKAGE MULTIFUNCTIONAL SSQ RESINS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-09-11 | — | — | WO | claimed |
| JP-2009522001-A | — | — | 2009-06-11 | — | — | JP | claimed |
| EP-1973513-A2 | LIGHT-CURABLE BONE GROWTH MATERIAL FOR TREATING DENTAL BONE DEFECTS | DENTSPLY INTERNATIONAL, INC. (US) | 2008-10-01 | — | — | EP | claimed |
| US-20080230167-A1 | Adhesive and method for binding artificial plastic teeth | DENTSPLY RESEARCH AND DEVELOPMENT CORP. (US) | 2008-09-25 | — | — | US | claimed |
| EP-1924235-A2 | ADHESIVE AND METHOD FOR BONDING ARTIFICIAL PLASTIC TEETH | DENTSPLY INTERNATIONAL, INC. (US) | 2008-05-28 | — | — | EP | claimed |
| US-20080041520-A1 | Adhesive and method for binding artificial plastic teeth | DENTSPLY RESEARCH AND DEVELOPMENT CORP. (US) | 2008-02-21 | — | — | US | claimed |
| US-20070269518-A1 | Light-curable bone growth material for treating dental bone defects | WALLINE KATHERINE S | 2007-11-22 | — | — | US | claimed |
| WO-2007079053-A2 | LIGHT-CURABLE BONE GROWTH MATERIAL FOR TREATING DENTAL BONE DEFECTS | DENTSPLY INTERNATIONAL INC. (US) | 2007-07-12 | — | — | WO | claimed |
| WO-2007022503-A2 | ADHESIVE AND METHOD FOR BONDING ARTIFICIAL PLASTIC TEETH | DENTSPLY INTERNATIONAL INC. (US) | 2007-02-22 | — | — | WO | claimed |
| US-4107845-A | SELF-CURING, INORGANIC FIBER FILLER, ACRYLATE POLYMER, PEROXIDE CATALYST | LEE PHARMACEUTICALS (US) | 1978-08-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130213549-A1 | ADHESIVE AND METHOD FOR BINDING ARTIFICIAL PLASTIC TEETH | MECP2, HDAC10, DNMT1 | TDP1 3358/4885CYP3A4 4671/4885ALDH1A1 2208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.